Framework agreement for Aflibercept supply
Originaltitel der Bekanntmachung
Belgium – Various medicinal products – Raamovereenkomst voor de levering van Aflibercept
Opportunity Score
Warum diese Bewertung?
Chance
65 / 100
Komplexität
60 / 100
Risikofaktoren
Lot 1 requires Creditsafe score A, B, or C. Bidders without a good financial score will be excluded. The buyer checks t...
Lot 2 requires a valid FAGG license for distribution. Bidders without this license cannot bid on Lot 2.
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Eckdaten der Ausschreibung
- Öffentlicher Auftraggeber
- AZ Sint-Lucas vzw
- Land
- Belgien
- CPV
- 33690000 - Various medicinal products
- Frist
- Jul 31, 2026
- Geschätzter Wert
- EUR 5.8M
Überblick
Moderate opportunityWichtige Fakten
- EUR 5.8M estimated value
- Framework procurement
- Supplies contract
- 3 lots
- Duration until Sep 2030
- Supply of Aflibercept (40mg/1ml) medicinal products in two forms: prefilled syringes and vials.
- Three lots corresponding to different product forms and therapeutic indications.
Vollständige Zusammenfassung anzeigen
This is an open tender from AZ Sint-Lucas vzw in Belgium for the supply of Aflibercept (40mg/1ml) medicinal product. It is divided into three lots: Lot 1 covers prefilled syringes for multiple ophthalmic indications, Lot 2 covers prefilled syringes for retinopathy of prematurity (ROP), and Lot 3 covers vials. Each lot is a framework agreement with a 2-year initial term and two silent 1-year extensions. The total maximum framework value across all lots is EUR 5,803,284 (from XML notice). Award is based primarily on price (82-87%) with quality subcriteria. Electronic submission is required through publicprocurement.be. The tender language is Dutch only. Key risks include short submission window, strict eligibility criteria (financial standing, FAGG license, ESPD), and potential inconsistencies in EU funding status. Procurement documents were not analyzed.
Risiken
Lot 1 requires Creditsafe score A, B, or C. Bidders without a good financial score will be excluded. The buyer checks t...
Lot 2 requires a valid FAGG license for distribution. Bidders without this license cannot bid on Lot 2.
Analyse kann unvollständig sein
Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.
Wichtige Anforderungen
Administrative
- Submission language: Dutch only.
- Electronic submission via publicprocurement.be is mandatory.
- Bidders can submit for up to 3 lots.
Anforderungen können unvollständig sein.
Zuschlagskriterien
Lot 1
Lot 2
Lot 3
Auftraggeber
Ort
Brugge, BEL
Website
Auftraggeberprofil
Kennung
408.116.216
Tätigkeit
Health
Lose (3)
LOT-0001
Aflibercept Pre-filled Syringe – Multiple Indications
Supply of Aflibercept (40mg/1ml) prefilled syringe registered for: neovascular age-related macular degeneration, visual impairment due to macular edema secondary to retinal vein occlusion, diabetic macular edema, and myopic choroidal neovascularization.
EUR 5.7M
Geschätzter Wert
Ort
Dauer
Kategorie
Zuschlagskriterien
Frist
Zuschlagsdetails
Prijs
flexibiliteit van de bewaarcondities
Gebruiksgemak en veiligheid
Productieplaats
Hinweis zum Wert
Maximalwert der Rahmenvereinbarung
Originale TED-Daten anzeigen
Originaler Los-Titel
Aflibercept (40mg/1ml) - Voorgevulde spuit
Originale TED-Beschreibung
geregistreerd voor volgende indicaties: 1. neovasculaire (natte) leeftijdsgebonden maculadegeneratie (LMD) 2. visusverslechtering als gevolg van macula-oedeem secundair aan retinale veneuze occlusie 3. visusverslechtering als gevolg van diabetisch macula-oedeem (DME) 4. visusverslechtering als gevolg van myope choroïdale neovascularisatie (myope CNV)
LOT-0002
Aflibercept Pre-filled Syringe – ROP
Supply of Aflibercept (40mg/1ml) prefilled syringe registered for the treatment of retinopathy of prematurity (ROP).
EUR 8.5k
Geschätzter Wert
Ort
Dauer
Kategorie
Zuschlagskriterien
Frist
Zuschlagsdetails
Prijs
flexibiliteit van de bewaarcondities
Gebruiksgemak en veiligheid
Productieplaats
Hinweis zum Wert
Maximalwert der Rahmenvereinbarung
Originale TED-Daten anzeigen
Originaler Los-Titel
Aflibercept (40mg/1ml) - Voorgevulde spuit
Originale TED-Beschreibung
geregistreerd voor de volgende indicatie: 1. de behandeling van een oogaandoening met de naam prematuren-retinopathie (ROP)
LOT-0003
Aflibercept Vial
Supply of Aflibercept (40mg/1ml) in vial form.
EUR 98.4k
Geschätzter Wert
Ort
Dauer
Kategorie
Zuschlagskriterien
Frist
Zuschlagsdetails
Prijs
flexibiliteit van de bewaarcondities
Productieplaats
Hinweis zum Wert
Maximalwert der Rahmenvereinbarung
Originale TED-Daten anzeigen
Originaler Los-Titel
Aflibercept (40mg/1ml) - Flacon
Originale TED-Beschreibung
Aflibercept (40mg/1ml) - Flacon
Vergabedetails
- Veröffentlichungsdatum
- 01 Jul 2026
- Sprachen
- Dutch
Referenzmetadaten
- Rechtsgrundlage
- 32014L0024
Referenz-IDs
- Ausschreibungs-ID
- 455937-2026
Dokumente (2)
Ähnliche Ausschreibungen
Spain – Various medicinal products – Suministro de medicamentos destinado a terapias genicas mediante SDA
Italy – Various medicinal products – Bando V SDA farmaci
Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на КОЦ-Русе ЕООД
Italy – Various medicinal products – ARIA_2025_045
Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на УМБАЛ "Царица Йоанна-ИСУЛ" ЕАД
Italy – Various medicinal products – Bando SDA Farmaci, Emoderivati, Vaccini e Mezzi di contrasto - Terza edizione
Opportunity Score
Warum diese Bewertung?
Chance
65 / 100
Komplexität
60 / 100
Risikofaktoren
Lot 1 requires Creditsafe score A, B, or C. Bidders without a good financial score will be excluded. The buyer checks t...
Lot 2 requires a valid FAGG license for distribution. Bidders without this license cannot bid on Lot 2.
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications